Evidence map›Paper›PMID 39330012›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, Mustafa Korkmaz, Dilek Erdem, Umut Cakıroglu, Mustafa Karaca, Ahmet Dirican, Omer Fatih Olmez, Sabin Goktas Aydın and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Birol OcakDepartment of Medical Oncology, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16350, Turkey.ORCID 0000-0001-7537-1699
Ahmet Bilgehan SahinDepartment of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey.
Ismail ErtürkDepartment of Medical Oncology, Gulhane School of Medicine, University of Health Sciences, Ankara 06018, Turkey.
Mustafa KorkmazDepartment of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey.
Dilek ErdemDepartment of Medical Oncology, VM Medical Park Samsun Hospital, Samsun 55200, Turkey.
Umut CakırogluDepartment of Medical Oncology, Van Training and Research Hospital, University of Health Sciences, Van 65300, Turkey.
Mustafa KaracaDepartment of Medical Oncology, Antalya Training and Research Hospital, University of Health Sciences, Antalya 07100, Turkey.
Ahmet DiricanDepartment of Medical Oncology, School of Medicine, Celal Bayar University, Manisa 45140, Turkey.
Omer Fatih OlmezDepartment of Medical Oncology, Medipol University Hospital, Istanbul 34810, Turkey.
Sabin Goktas AydınDepartment of Medical Oncology, Medipol University Hospital, Istanbul 34810, Turkey.
Ali GökyerDepartment of Medical Oncology, Department of Internal Medicine, School of Medicine, Trakya University, Edirne 22130, Turkey.
Ahmet KücükardaDepartment of Medical Oncology, Department of Internal Medicine, School of Medicine, Trakya University, Edirne 22130, Turkey.
Ahmet GülmezDepartment of Medical Oncology, School of Medicine, Inonu University, Malatya 44280, Turkey.
Perran Fulden YumukDepartment of Medical Oncology, School of Medicine, Marmara University, Istanbul 34854, Turkey.
Nazim Can DemircanDepartment of Medical Oncology, School of Medicine, Marmara University, Istanbul 34854, Turkey.
Abdilkerim OymanDepartment of Medical Oncology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul 34764, Turkey.
Teoman SakalarDepartment of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaraş 46050, Turkey.
Fatih KaratasDepartment of Medical Oncology, Faculty of Medicine, Karabuk University, Karabuk 78100, Turkey.
Hacer DemirDepartment of Medical Oncology, Afyonkarahisar Health Sciences University, Afyon 03030, Turkey.
Ayse Irem YasinDepartment of Medical Oncology, Faculty of Medicine, Bezmialem Vakif University, Istanbul 34093, Turkey.ORCID 0000-0002-1528-8065
Adem DeligonulDepartment of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey.
Bahar DakikiDepartment of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey.ORCID 0000-0001-9255-2475
Mehmet Refik GoktugDepartment of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey.
Okan AvcıDepartment of Medical Oncology, Tekirdağ Namık Kemal University, Tekirdağ 34093, Turkey.
Seher Yildiz TacarDepartment of Medical Oncology, Tekirdağ Namık Kemal University, Tekirdağ 34093, Turkey.
Nazım Serdar TurhalDepartment of Medical Oncology, Anadolu Health Center, Kocaeli 2255, Turkey.ORCID 0000-0002-1013-5676
Gülhan Ipek DenizDepartment of Medical Oncology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul 34371, Turkey.
Turgut KacanDepartment of Medical Oncology, Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa 16350, Turkey.
Erdem CubukcuDepartment of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey.
Türkkan EvrenselDepartment of Medical Oncology, School of Medicine, Bursa Uludag University, Bursa 16059, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellCytoreduction Surgical ProceduresKidney NeoplasmsNephrectomyNivolumabAdultAgedAntineoplastic Agents, ImmunologicalFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeAntineoplastic Agents, ImmunologicalNivolumabclear-cell renal-cell carcinomacytoreductive nephrectomynivolumabsurvival

Identifiers

PMID39330012
PMCPMC11431784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.